IBM supercomputer to aid osteoporosis treatment
IBM says it has developed a way to use one of its supercomputers to improve diagnosis and treatment of the widespread bone disease osteoporosis.
IBM Zurich Research Laboratory and the Swiss Federal Institute of Technology Zurich (also known as ETH Zurich) utilized an IBM supercomputer to develop a method of early diagnosis that they say trumps the current approach to measuring bone mass density, the computer company announced Monday.
According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the current most widely recognized bone mass density test is conducted by a dual-energy X-ray absorptiometry, or DXA. However, the test cannot measure the spongy inner microstructure of the bone.
